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Background: Calcification of homografts and vascular conduits is poorly under-
stood. Mechanisms leading to calcification were studied in a rat model of aortic
allografts.
Methods: Rat aortas from Lew1W (RT1u) were transplanted into Lew1A (RT1a).
Animals were killed at 30 days and 180 days, and aortic grafts were removed and
analyzed for histologic and immunohistologic studies.
Results: Intimal surface increased progressively over 6 months and was the site of
important modifications. Intimal cellular population changed from a leukocyte
(CD45, OX1-OX30)- and macrophage (CD68, ED-1)-based population at 30 days to
predominantly -smooth muscle actin-expressing cells at 180 days. At 180 days,
allografts were characterized by an abundant extracellular matrix composed of
collagen and elastic fibers associated with extensive calcification (von Kossa stain-
ing) located in the intima and media. Osteoblastic activity was present in calcified
lesion as shown by alkaline phosphatase activity. At 180 days, numerous chondro-
cytes (protein S100-positive and -smooth muscle actin-negative) were present
focally in the media. However, double immunostaining revealed that a cellular
population within the media with a chondrocyte-like morphology was -smooth
muscle actin-positive and S100-negative. Active form of transforming growth factor
1 was expressed from 30 to 80 days in the medial and intimal layers.
Conclusions: These observations suggest that -smooth muscle actin-positive cells
within aortic allografts are eventually transformed to a chondrocyte-like structure,
leading to vascular cartilaginous metaplasia associated with the expression of
transforming growth factor 1 and could be a potential pathway leading to extensive
vascular wall calcification in allografts through endochondral ossification.
Calcification of vascular structures has been linked to differentdiseases such as atherosclerosis, cardiac valve disease, calcificuremic arteriolopathy, and transplant arteriosclerosis.1,2 Intimalcalcification has been linked to end-stage chronic renal allograftrejection.3 Allograft conduit wall calcification is an important path-way leading to conduit graft failure, particularly in young patients.4
Mechanisms leading to allograft calcification are still ill defined. Until recently,
vascular calcification and aortic allograft calcification were considered to be passive
processes. However, observations suggest that calcified tissue express bone matrix
proteins involved in the calcifying process.5 Elaboration of promineralizing matrix
by the aortic allograft might be implicated in the heterotopic calcification process.
The origin of promineralizing cells within the vascular wall remains unknown. It is
hypothesized that these cells are either derived from blood-borne cells that invade
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the arterial wall or are native vascular cells with a dediffer-
entiation potential toward bone-forming cells.6
Cytokines or growth factors might be implicated in trans-
formation of native or infiltrating vascular cells to calcifying
vascular cells. In vitro, implication of growth factors such as
transforming growth factor 1 (TGF--1) leading to trans-
formation of vascular cells to calcifying cells has been
described.7 We have used a model of aortic transplantation
in the rat to study allograft arteriosclerosis and calcifying
degeneration. Early expression of active form of TGF-1
after transplantation was associated with the development of
graft cartilaginous metaplasia and endochondral ossifica-
tion. Our data confirm that a population of -smooth muscle
actin-expressing cells within the aortic allograft are mor-
phologically a chondrocyte-like structure that might repre-
sent an intermediary form preceding a fully mature chon-
drocyte.
Methods
Animals and Aorta Transplantation
Transplantations were performed using 250-g inbred male Lewis
1W (LEW.1W, haplotype RT1u) as donors and Lew.1A (RT1a) as
recipients (CERJ, Le Genest St Isle, France). These animals are
completely mismatched for the entire major histocompatibility
complex region. The descending thoracic aorta was harvested from
the donor and then anastomosed to the recipient’s abdominal aorta
below the renal arteries and above the aortic bifurcation. Anasto-
moses were done as previously described8 using termino-lateral
technique at both proximal and distal ends of the allograft, and the
native aorta was ligated between the anastomosis. Grafted aortas
(allografts and isografts) were harvested at 30 (n  6) and 180 (n
 4) days after transplantation. Harvested segments were cut into
2 equal pieces, and 1 segment was fixed with formaldehyde 10%
for histologic processing. The proximal and distal anastomosis
parts were discarded to eliminate potential healing effects. Cross
sections of fixed segments were stained with hematoxylin-eosin
(H&E), von Weigert (for elastic fibers), trichrome Masson (for
collagen), and von Kossa (for mineralization). The other segment
was embedded in optimum cutting temperature (OCT) compound
(TissueTek, Miles Laboratories, Elkhart, Ind) and frozen liquid
nitrogen for immunohistologic analysis.
Immunohistologic Analysis
Immunohistology was performed in cryostat sections as previously
described in detail.9 Immunohistologic analysis of infiltrating leu-
kocytes was performed using the following mouse Mab: a mixture
of 2 anti-leukocytes CD45 Mabs (OX1 and OX30), anti-monocyte/
macrophage CD68 (ED1), anti- T-cell receptor (TCR) (R.7.3)
(all from ECACC, Wiltshire, United Kingdom), anti- smooth
muscle actin (SMC) (Sigma, St Louis, Mo), anti-active form of
TGF-1 (R&D Systems, Inc, Minneapolis, Minn), and an irrele-
vant mouse Mab (3G8, anti-human CD16). Slides were then in-
cubated with a biotin-conjugated anti-mouse immunoglobulin an-
tibody (Vector Laboratories, Burlingame, Calif), followed by
horseradish peroxide-conjugated streptavidin (Vector Laborato-
ries). S100 protein (a useful marker for chondrocytes) was detected
using rabbit Mab (DAKO Corporation, Carpinteria, Calif). Biotin-
conjugated anti-rabbit antibody were from Jackson Laboratory,
Bar Harbor, Maine. Binding of these antibodies was detected by
incubation with horseradish peroxidase-conjugated streptavidin
and VIP or DAB substrate (Vector Laboratories). Double immu-
nostaining for S100 and  SMC actin was used with the following
protocol: slides were first incubated with mouse anti- SMC actin
(Sigma) and followed with biotin-conjugated anti-mouse antibody
(Jackson Laboratories). Binding of biotin-conjugated antibody was
detected by incubation with horseradish peroxidase-conjugated
straptavidin and DAB substrate (Vector Laboratories). Then S100
protein was detected using rabbit anti-S100 protein (DAKO) fol-
lowed by phosphatase alkaline-conjugated antibody and revealed
with Vector Blue (Vector Laboratories) and levamisol.
Alkaline Phosphatase Activity
Cryostat sections of aortic graft tissue were incubated for an hour
with Vector Blue alkaline phosphatase substrate kit (Vector Lab-
oratories). Then slides were mounted for analysis.
Results
At day 30, allografts were heavily infiltrated by leukocytes
(CD45), and the cellular population was composed of T
cells ( TCR) and macrophages (ED1) infiltrating intima
and adventitia (Figure 1). At day 180, intima of allografts
showed an impressive decrease of inflammatory cellular
population such as leukocytes (CD45), macrophages (ED1),
and T cells ( TCR; Figure 1). At day 180 cellular pop-
ulation within the intima was predominantly represented
with -smooth muscle actin-expressing cells (data not
shown). At day 180, cells with the histologic appearance of
chondrocytes were present focally in the intima of all (4/4
animals) allografts (Figure 2). Immunohistochemical stud-
ies revealed that most of these cells were S100-positive and
therefore were chondrocytes (Figure 2). A few cells had a
chondrocyte-like structure but were S100-negative. Double
immunostaining technique showed that these chondrocyte-
like cells were S100-negative and -smooth muscle actin-
positive, suggesting that these cells might be derived from
smooth muscle cell precursor or other -smooth muscle
actin-expressing cells such as pericyte (Figure 3).
Because chondrogenesis is often followed by osteogen-
esis, we tested harvested allografts at day 180 for the
presence of calcification. Staining for mineralized tissue
(von Kossa) showed the presence of calcification located at
the interface between the intima and the media with inva-
sion of the latter layer, and these calcified lesions had
alkaline phosphatase activity, indicating osteogenesis activ-
ity (Figure 4). Furthermore, calcified arteries were fibrotic,
as demonstrated with collagen deposition (trichrome Mas-
son staining) throughout the vascular wall (Figure 4). Elas-
tic fibers (von Weigert staining) were detected in the intima
following a reticular pattern (Figure 4).
To investigate whether TGF-1 might be associated with
vascular cartilaginous metaplasia, we conducted immuno-
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histologic studies on aortic grafts. In control isografts,
TGF-1 was expressed in the media at both 30 and 180
days. However, at 30 days, allografts had a stronger expres-
sion of TGF-1 located in the intima and the media that
persisted until day 180. At day 180, TGF-1 was expressed
by intimal cells, medial cells, and by chondrocyte or chon-
drocyte-like cells (Figure 5).
Discussion
Clinically, allograft conduits used for complex congenital
heart disease or aortic valve allograft are prone to calcifi-
cation, particularly in young patients. The calcification pro-
cess in either aortic conduit or aortic valve is associated
with functional failure of the graft. However, allograft cal-
cification and failure proceeds through still ill-defined
mechanisms. This experimental study showed that cartilag-
inous metaplasia and osteogenesis was associated with het-
erotopic calcification in aortic allograft. These calcifications
were specific to aortic allografts and were not detected in
either isograft or native arteries (data not shown) of the
transplanted animals. Therefore, host immune responses
against alloantigens are involved in this model of hetero-
Figure 1. Cellular infiltration of aortic allografts at 1 month and 6 months. Immunohistology for CD45 (leukocytes),
CD68 (macrophages), and T cells (-TCR).
Figure 2. A, Aortic allografts at 6 months. H&E staining shows cells with histologic appearance of chondrocytes.
B, Immunohistologic preparation showing S100-positive cells within the intima confirming the presence of
chondrocytes.
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topic calcification. We explored in vivo mechanisms lead-
ing to heterotopic calcification, and we found that a popu-
lation of precursor cells in the arterial wall expressing
-smooth muscle actin might be involved in the metaplasic
process and subsequent calcification.
Heterotopic calcification is an active process that in-
volves osteoblastic activity.10 Endochondral osteogenesis
similar to that observed in the growth plate has been shown
to be present in human stenotic heart valves.10 Secretion of
promineralizing extracellular matrix composed of different
proteins such as osteocalcin, osteopontin, and bone morpho-
genetic protein-2 (BMP-2) have been documented in calci-
fied atherosclerotic lesions, indicating a process similar to
what is observed in bone mineralization.11-13 Alkaline phos-
phatase activity has been demonstrated in our calcified
allografts, suggesting similarities to osteogenesis. In vitro,
alkaline phosphatase activity in bovine smooth muscle cells
has been shown to be essential for the mineralization pro-
cess.14 Therefore, our model suggests that a process similar
to osteogenesis is involved in aortic allograft calcification.
This process of calcification was triggered by the immune
response since isografts retained a normal histology. This is
in accordance with human studies that suggest an immune
response against alloantigens in homografts recipients.15,16
However, others studies have stressed the role of preserva-
tion, donor age, and the viability of homografts as factors
involved in allografts structural failure.17
Mineralization of vascular tissue proceeds from differ-
entiation of pluripotent mesenchymal cells to calcifying
cells. In vitro, smooth muscle cells exposed to vitamin D,
warfarin, and high phosphate concentration induced miner-
alization process, with development of osteoblastic differ-
entiation markers.18,19 In vitro, a population of bovine and
human cells from the arterial wall undergoes spontaneous
calcification.6 These calcifying vascular cells share many
similarities with microvascular pericyte. Pericytes have
been reported to be precursors of osteoblasts and smooth
muscle cells.20 Heterotopic endochondral ossification in
atherosclerotic plaque has been shown to proceed from cells
that resemble microvascular pericytes.21 We found in aortic
allografts that mature chondrocytes expressing S100 protein
were present in the vascular wall. However, a small popu-
lation of chondrocyte-like cells were S100-negative but
-smooth muscle actin-positive, suggesting that a precursor
cell expressing -smooth muscle actin might be involved in
the metaplasic process. Both smooth muscle cells and peri-
cytes have been shown to express -smooth muscle actin.
Therefore, 1 or both of these cells might be involved in the
pathologic process of heterotopic calcification through en-
dochondral ossification.
Heterotopic calcification through endochondral ossifica-
tion from pericytes has been shown to be influenced by
cytokines and growth factors produced by immune cells.22
Members of the TGF- family have been associated with
chondrogenesis in the skeletal system.23 Cartilaginous
metaplasia in the cardiovascular system has been described
in human heart valves and in aortas of atherosclerotic mice
but no association with TGF- was made.24,25 However, in
vivo, transfection and local expression of TGF-1 in rat
aorta induced a cartilaginous metaplasia that was reversible
when TGF-1 expression was stopped.26 In vitro, cellular
populations within the aortic wall that spontaneously cal-
cify, called “calcifying vascular cells,” are stimulated by
TGF-17 These calcifying vascular cells are -smooth mus-
cle actin-positive, suggesting that they are derived from
either smooth muscle cells or from pericytes. In aortic
allografts, we found that cartilaginous metaplasia and cal-
cification was associated with early expression of TGF-1
throughout the study period until 6 months after grafting.
However, in our model no causal effect can be drawn from
the association of TGF-1 expression and vascular cartilag-
inous metaplasia as it is an observational study. In fact, the
pathogenic role of the pleiotropic growth factor, TGF-1, is
still subjected to controversies and to some point poorly
understood.27 Several studies have associated TGF-1 ex-
pression with the development of vascular disease, whereas
others studies have demonstrated that the expression of
TGF-1 prevents arterial vascular disease.27-29 Apparently
such diverse effect of TGF-1 on the biology of the vascu-
lar system might be related to the signals delivered accord-
ing to the state of differentiation of the cells and their
Figure 3. Double immunostaining technique showed that a few
cells within the intima of aortic allograft at 6 months had a
chondrocyte-like structure and were -actin-positive (brown
cell) and S100-negative, whereas most of them were S100-posi-
tive (blue cell), indicating the presence of chondrocytes.
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qualitative and quantitative expression of different type of
TGF receptors.30
Interactions between different inflammatory pathways
and specific mechanisms leading to heterotopic calcification
are still poorly understood. Different molecules such as
vitamin D, phosphate, steroids, warfarin, and cytokines
might be involved in the calcification process.14,31,32 It is
likely that activation of graft infiltrating cells and native
vascular cells leads to local production of cytokines and
growth factors that are involved in the heterotopic process
of calcification of the aortic allograft. However, the specific
nature and interaction between different cytokines and
Figure 4. A, Aortic allografts at 6 months showed extensive calcification located between the intima and media
(von Kossa staining). B, Osteoblastic activity was confirmed with alkaline phosphatase staining (blue). C, Presence
of extensive fibrosis was confirmed with trichrome Masson staining. D, Deposition of a reticular pattern of elastin
was found at the basal layer of the intima.
Figure 5. At 6 months, immunohistochemical studies showed the expression of the active form of TGF-1 in aortic
isografts (A), which was located in the media. In allografts (B), a stronger expression of TGF 1 was found in the
media and intima.
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growth factors leading to transformation of cells into bone-
forming cells is still an embryonic field. Prevention of
heterotopic calcification of the aortic allograft would lead to
better long-term function of aortic allografts. Therefore,
understanding expression and physiology of growth factors
in the aortic allograft could provide important insight into
the pathophysiology of heterotopic calcification process.
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